EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis European Association for the Study of the Liver ⇑ , Asociación Latinoamericana para el Estudio del Hígado

[1]  M. N. Kim,et al.  Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography–defined subclinical cirrhosis , 2015, Hepatology.

[2]  A. Burt,et al.  Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. , 2015, Journal of hepatology.

[3]  Mats Fredrikson,et al.  Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.

[4]  M. Ronot,et al.  Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. , 2015, Radiology.

[5]  Lee-Jen Wei,et al.  Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  Zhen Wang,et al.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  E. Tapper,et al.  Contemporary assessment of hepatic fibrosis. , 2015, Clinics in liver disease.

[8]  A. Burroughs,et al.  Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. , 2015, The Cochrane database of systematic reviews.

[9]  V. de Lédinghen,et al.  Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®). , 2014, Journal of hepatology.

[10]  Marcello Maida,et al.  Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. , 2014, Journal of hepatology.

[11]  Julien Vergniol,et al.  Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®. , 2014, Journal of hepatology.

[12]  S. Ahn,et al.  Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy , 2014, The American Journal of Gastroenterology.

[13]  L. Chrostek,et al.  Liver fibrosis markers in alcoholic liver disease. , 2014, World journal of gastroenterology.

[14]  P. Faure,et al.  Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C. , 2014, Journal of hepatology.

[15]  S. Bertrais,et al.  Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C , 2014, Hepatology.

[16]  J. Hernández-Quero,et al.  Letter: accuracy of liver stiffness measurement – a comparison of two different FibroScan devices , 2014, Alimentary pharmacology & therapeutics.

[17]  G. Casazza,et al.  Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. , 2014, Journal of hepatology.

[18]  N. Shin,et al.  Transient Elastography and Sonography for Prediction of Liver Fibrosis in Infants With Biliary Atresia , 2014, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[19]  A. Burroughs,et al.  Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis. , 2014, Journal of hepatology.

[20]  G. Kaplan,et al.  Liver Stiffness by Transient Elastography Predicts Liver-Related Complications and Mortality in Patients with Chronic Liver Disease , 2014, PloS one.

[21]  F. Carrat,et al.  Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. , 2014, Gastroenterology.

[22]  V. de Lédinghen,et al.  Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®). , 2014, Journal of hepatology.

[23]  Sheng-Nan Lu,et al.  The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy , 2014, PloS one.

[24]  Simona Bota,et al.  The role of ultrasound elastographic techniques in chronic liver disease: current status and future perspectives. , 2014, European journal of radiology.

[25]  S. Bertrais,et al.  Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C , 2014, Journal of Gastroenterology.

[26]  J. Stoker,et al.  Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C , 2014, European Radiology.

[27]  V. Wong,et al.  Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. , 2014, Journal of hepatology.

[28]  X. Forns,et al.  Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  G. Wong,et al.  Non‐invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B , 2014, Alimentary pharmacology & therapeutics.

[30]  T. Ichida,et al.  Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon‐based anti‐viral therapy , 2014, Journal of gastroenterology and hepatology.

[31]  V. Paradis,et al.  Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non‐invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration , 2014, HIV medicine.

[32]  U. d’Alessandro,et al.  Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia , 2014, Alimentary pharmacology & therapeutics.

[33]  Anil T Ahuja,et al.  Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. , 2013, Radiology.

[34]  F. Bronte,et al.  Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis , 2013, Journal of viral hepatitis.

[35]  Laurent Castera,et al.  Noninvasive evaluation of NAFLD , 2013, Nature Reviews Gastroenterology &Hepatology.

[36]  P. Das,et al.  Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B , 2013, Journal of gastroenterology and hepatology.

[37]  Ioan Sporea,et al.  Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. , 2013, Ultrasound in medicine & biology.

[38]  C. Tural,et al.  Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients , 2013, AIDS.

[39]  S. Ahn,et al.  Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model , 2013, OncoTargets and therapy.

[40]  J. Ward,et al.  The new paradigm of hepatitis C therapy: integration of oral therapies into best practices , 2013, Journal of viral hepatitis.

[41]  S. Milani,et al.  Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[42]  E. Bjornsson,et al.  Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. , 2013, Gastroenterology.

[43]  Christine Katlama,et al.  Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C. , 2013, Journal of hepatology.

[44]  M. Friedrich-Rust,et al.  The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[45]  R. Badea,et al.  Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness? , 2013, Journal of gastrointestinal and liver diseases : JGLD.

[46]  Ioan Sporea,et al.  Meta‐analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[47]  P. Bedossa,et al.  A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. , 2013, Journal of hepatology.

[48]  P. Lampertico,et al.  Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection , 2013, Journal of viral hepatitis.

[49]  V. Paradis,et al.  The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. , 2013, Journal of hepatology.

[50]  A. Berzigotti,et al.  Update on ultrasound imaging of liver fibrosis. , 2013, Journal of hepatology.

[51]  Elie A Akl,et al.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. , 2013, Journal of clinical epidemiology.

[52]  G. Bedogni,et al.  Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution , 2013, Hepatology.

[53]  Eva Herrmann,et al.  The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis , 2013, European Radiology.

[54]  Ngoc Wasson,et al.  Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection , 2013, Annals of Internal Medicine.

[55]  T. Asselah,et al.  Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus , 2013, Alimentary pharmacology & therapeutics.

[56]  Dominique Thabut,et al.  Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. , 2013, Journal of hepatology.

[57]  V. Wong,et al.  NAFLD in Asia—as common and important as in the West , 2013, Nature Reviews Gastroenterology &Hepatology.

[58]  Sheng-Nan Lu,et al.  Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[59]  Ashish Kumar,et al.  Spleen Stiffness in Patients With Cirrhosis in Predicting Esophageal Varices , 2013, The American Journal of Gastroenterology.

[60]  M. Friedrich-Rust,et al.  Acoustic radiation force impulse imaging for non‐invasive assessment of liver fibrosis in chronic hepatitis B , 2013, Journal of viral hepatitis.

[61]  S. Bota,et al.  The influence of food intake on liver stiffness values assessed by acoustic radiation force impulse elastography-preliminary results. , 2013, Ultrasound in medicine & biology.

[62]  T. Therneau,et al.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States , 2013, Hepatology.

[63]  F. Schaefer,et al.  EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology , 2013, Ultraschall in der Medizin.

[64]  A. de Gottardi,et al.  Effect of Meal Ingestion on Liver Stiffness in Patients with Cirrhosis and Portal Hypertension , 2013, PloS one.

[65]  V. de Lédinghen,et al.  Determination of reliability criteria for liver stiffness evaluation by transient elastography , 2013, Hepatology.

[66]  John F. Flaherty,et al.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study , 2013, The Lancet.

[67]  P. Brissot,et al.  Effect of alcohol consumption on liver stiffness measured by transient elastography. , 2013, World journal of gastroenterology.

[68]  M. Zheng,et al.  Transient elastography: a meta‐analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[69]  P. Roderick,et al.  Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease , 2012, Comparative hepatology.

[70]  Ioan Sporea,et al.  Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. , 2012, European journal of radiology.

[71]  G. Ferraioli,et al.  Accuracy of real‐time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study , 2012, Hepatology.

[72]  V. Wong,et al.  Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease , 2012, The American Journal of Gastroenterology.

[73]  Jun Yong Park,et al.  Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis , 2012, PloS one.

[74]  G. Casazza,et al.  Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. , 2012, Gastroenterology.

[75]  Rosa Gilabert,et al.  ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. , 2012, Journal of hepatology.

[76]  S. Pol,et al.  Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. , 2012, Alcoholism, clinical and experimental research.

[77]  Ioan Sporea,et al.  Comparative study concerning the value of acoustic radiation force impulse elastography (ARFI) in comparison with transient elastography (TE) for the assessment of liver fibrosis in patients with chronic hepatitis B and C. , 2012, Ultrasound in medicine & biology.

[78]  V. Paradis,et al.  A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis , 2012, Hepatology.

[79]  F. Nevens,et al.  EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease , 2012 .

[80]  Ioan Sporea,et al.  Intra- and interoperator reproducibility of acoustic radiation force impulse (ARFI) elastography--preliminary results. , 2012, Ultrasound in medicine & biology.

[81]  J. Macías,et al.  Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis , 2012, Hepatology.

[82]  A. Lok,et al.  Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. , 2012, Journal of hepatology.

[83]  F. Carrat,et al.  Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis , 2012, Hepatology.

[84]  S. Ahn,et al.  The Accuracy of Noninvasive Methods in Predicting the Development of Hepatocellular Carcinoma and Hepatic Decompensation in Patients With Chronic Hepatitis B , 2012, Journal of clinical gastroenterology.

[85]  P. Parrilla,et al.  Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging , 2012, European Radiology.

[86]  H. Zhuang,et al.  [Updates of EASL clinical practice guidelines: management of chronic hepatitis B virus infection]. , 2012, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[87]  Jia-Horng Kao,et al.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update , 2012, Hepatology International.

[88]  Y. N. Park,et al.  Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis , 2012, PloS one.

[89]  T. Reiberger,et al.  Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis , 2012, Journal of Gastroenterology.

[90]  Y. N. Park,et al.  Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B , 2012, PloS one.

[91]  T. Asselah,et al.  Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[92]  V. Wong,et al.  Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. , 2012, Journal of hepatology.

[93]  M. Friedrich-Rust,et al.  Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. , 2012, European journal of radiology.

[94]  J. Bosch,et al.  Non invasive evaluation of portal hypertension using transient elastography. , 2012, Journal of hepatology.

[95]  G. le Naour,et al.  Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. , 2012, Journal of hepatology.

[96]  Quanjiang Dong,et al.  Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis , 2012, BMC Gastroenterology.

[97]  S. Mehta,et al.  Transient elastography for predicting clinical outcomes in patients with chronic liver disease , 2012, Journal of viral hepatitis.

[98]  M. Lupsor,et al.  Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis , 2012, Journal of viral hepatitis.

[99]  K. Das,et al.  “Normal” liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population‐based study from a developing country , 2012, Hepatology.

[100]  S. Colombo,et al.  Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis , 2012, Journal of Gastroenterology.

[101]  A. Mangia,et al.  Comparison of three algorithms of non‐invasive markers of fibrosis in chronic hepatitis C , 2012, Alimentary pharmacology & therapeutics.

[102]  V. de Lédinghen,et al.  Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive , 2012, Hepatology.

[103]  A. Pollett,et al.  Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients , 2012, Hepatology.

[104]  M. Attanasio,et al.  Comparison of Transient Elastography and Acoustic Radiation Force Impulse for Non-Invasive Staging of Liver Fibrosis in Patients With Chronic Hepatitis C , 2011, The American Journal of Gastroenterology.

[105]  J. Hayashi,et al.  Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[106]  G. Musso,et al.  Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity , 2011, Annals of medicine.

[107]  A. Mangia,et al.  The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non‐invasive fibrosis biomarkers: an international study of 2411 cases , 2011, Alimentary pharmacology & therapeutics.

[108]  A. Floreani,et al.  Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[109]  J. Vinel,et al.  Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. , 2011, Journal of hepatology.

[110]  H. Hiraishi,et al.  Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[111]  Ned C. Rouze,et al.  Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. , 2011, Journal of hepatology.

[112]  J. Pawlotsky,et al.  Liver stiffness diminishes with antiviral response in chronic hepatitis C , 2011, Alimentary pharmacology & therapeutics.

[113]  Mathieu Couade,et al.  Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients. , 2011, Ultrasound in medicine & biology.

[114]  Vincent Wai-Sun Wong,et al.  Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography , 2011, Gut.

[115]  Koji Suzuki,et al.  Reduction of liver stiffness by antiviral therapy in chronic hepatitis B , 2011, Journal of Gastroenterology.

[116]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[117]  Michiie Sakamoto,et al.  Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan® , 2011, Journal of Gastroenterology.

[118]  I. Sporea,et al.  How efficient is acoustic radiation force impulse elastography for the evaluation of liver stiffness? , 2011, Hepatitis monthly.

[119]  M. Yuen,et al.  Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3‐year follow‐up study , 2011, Journal of viral hepatitis.

[120]  Julien Vergniol,et al.  Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. , 2011, Gastroenterology.

[121]  H. Makhlouf,et al.  Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality , 2011, Hepatology.

[122]  M. Manns,et al.  Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). , 2011, Digestive and Liver Disease.

[123]  A. Craxì,et al.  Reliability of liver stiffness measurement in non‐alcoholic fatty liver disease: the effects of body mass index , 2011, Alimentary pharmacology & therapeutics.

[124]  Y. Ngo,et al.  Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age , 2011, BMC gastroenterology.

[125]  G. Casazza,et al.  Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. , 2011, Journal of hepatology.

[126]  E. Cholongitas,et al.  Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. , 2011, Journal of hepatology.

[127]  N. Afdhal,et al.  The optimal cut‐off for predicting large oesophageal varices using transient elastography is disease specific , 2011, Journal of viral hepatitis.

[128]  S. Colombo,et al.  Normal liver stiffness and its determinants in healthy blood donors. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[129]  Ying Sun,et al.  Performance of the aspartate aminotransferase‐to‐platelet ratio index for the staging of hepatitis C‐related fibrosis: An updated meta‐analysis , 2011, Hepatology.

[130]  Young Ju Cho,et al.  Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. , 2011, Hepato-gastroenterology.

[131]  Y. N. Park,et al.  Risk assessment of hepatitis B virus–related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) , 2011, Hepatology.

[132]  G. Fattovich,et al.  Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) Imaging for the Diagnosis of Cirrhosis during Liver Ultrasonography , 2011, Ultraschall in der Medizin.

[133]  V. de Lédinghen,et al.  Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers , 2011, Alimentary pharmacology & therapeutics.

[134]  H. Chan,et al.  Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population , 2011, Journal of gastroenterology and hepatology.

[135]  E. Kouroumalis,et al.  Serum surrogate markers of liver fibrosis in primary biliary cirrhosis. , 2011, European journal of internal medicine.

[136]  V. Wong,et al.  On-Treatment Monitoring of Liver Fibrosis with Transient Elastography in Chronic Hepatitis B Patients , 2011, Antiviral therapy.

[137]  Y. Maehara,et al.  New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver , 2011, Journal of Gastroenterology.

[138]  Radu Badea,et al.  Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients , 2011, Journal of gastroenterology and hepatology.

[139]  X. Forns,et al.  Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C , 2011, Alimentary pharmacology & therapeutics.

[140]  P. Bedossa,et al.  Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). , 2010, Journal of hepatology.

[141]  P. Crotty,et al.  Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[142]  S. Bota,et al.  Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. , 2010, World journal of gastroenterology.

[143]  Sheng-Nan Lu,et al.  Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis , 2010, Hepatology international.

[144]  G. Fattovich,et al.  Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study. , 2010, Journal of hepatology.

[145]  E. Schiff,et al.  Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B , 2010, Hepatology.

[146]  F. Oberti,et al.  Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis , 2010, European journal of gastroenterology & hepatology.

[147]  A. Tamori,et al.  Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[148]  C. Tural,et al.  Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice , 2010, HIV medicine.

[149]  F. Carrat,et al.  Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. , 2010, Journal of hepatology.

[150]  Kunihiro Hosono,et al.  Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. , 2010, Radiology.

[151]  V. de Lédinghen,et al.  Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[152]  R. Fontana,et al.  Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C , 2010, Gut.

[153]  G. Alexander,et al.  Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease , 2010, Gut.

[154]  I. Sporea,et al.  Acoustic Radiation Force Impulse Elastography as Compared to Transient Elastography and Liver Biopsy in Patients with Chronic Hepatopathies , 2010, Ultraschall in der Medizin.

[155]  D. Capron,et al.  Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology. , 2010, Alcoholism, clinical and experimental research.

[156]  Vincent Wai-Sun Wong,et al.  Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years , 2010, Gut.

[157]  M. Friedrich-Rust,et al.  Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis , 2010, European Radiology.

[158]  Y. Paik,et al.  A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis , 2010, The American Journal of Gastroenterology.

[159]  T. Heeren,et al.  Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection , 2010, The American Journal of Gastroenterology.

[160]  G. Wong,et al.  Development of a non‐invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B , 2010, Alimentary pharmacology & therapeutics.

[161]  V. Wong,et al.  Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[162]  Hirokazu Takahashi,et al.  Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[163]  J. Cosín,et al.  Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus‐coinfected patients and correlation with noninvasive serum markers , 2010, Journal of viral hepatitis.

[164]  R. Goertz,et al.  Measurement of Liver Elasticity with Acoustic Radiation Force Impulse (ARFI) Technology: An Alternative Noninvasive Method for Staging Liver Fibrosis in Viral Hepatitis , 2010, Ultraschall in der Medizin.

[165]  V. de Lédinghen,et al.  Pitfalls of liver stiffness measurement: A 5‐year prospective study of 13,369 examinations , 2010, Hepatology.

[166]  Ioan Sporea,et al.  Acoustic Radiation Force Impulse (ARFI)--a new modality for the evaluation of liver fibrosis. , 2010, Medical ultrasonography.

[167]  G. Baffet,et al.  Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis. , 2010, Journal of hepatology.

[168]  B. Gazzard,et al.  A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis , 2010, Journal of clinical gastroenterology.

[169]  Z. Sparchez,et al.  Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. , 2010, Journal of gastrointestinal and liver diseases : JGLD.

[170]  Gunda Millonig,et al.  Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. , 2010, World journal of gastroenterology.

[171]  Gunda Millonig,et al.  Liver stiffness is directly influenced by central venous pressure. , 2010, Journal of hepatology.

[172]  Julien Vergniol,et al.  Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease , 2010, Hepatology.

[173]  V. de Lédinghen,et al.  Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. , 2010, Journal of hepatology.

[174]  S. Ahn,et al.  What are ‘true normal’ liver stiffness values using FibroScan®?: a prospective study in healthy living liver and kidney donors in South Korea , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[175]  A. Floreani,et al.  F.N.2 PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS , 2010 .

[176]  X. Forns,et al.  Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation , 2010, Hepatology.

[177]  Gabriela Marinoschi,et al.  Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis. , 2009, World journal of gastroenterology.

[178]  G. Raimondo,et al.  An evaluation of transient elastography in the discrimination of HBeAg‐negative disease from inactive hepatitis B carriers , 2009, Journal of viral hepatitis.

[179]  V. de Lédinghen,et al.  The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosis , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[180]  M. Manns,et al.  Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[181]  A. Burroughs,et al.  Prospective comparison of Fibroscan, King’s score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection , 2009, Journal of viral hepatitis.

[182]  A. Sanyal,et al.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[183]  B. McMahon,et al.  Chronic hepatitis B: Update 2009 , 2009, Hepatology.

[184]  Radu Badea,et al.  Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[185]  J. Hayashi,et al.  The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. , 2009, Antiviral research.

[186]  M. Friedrich-Rust,et al.  Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. , 2009, Radiology.

[187]  J. Macías,et al.  Liver Stiffness as a Predictor of Esophageal Varices Requiring Therapy in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis , 2009, Journal of acquired immune deficiency syndromes.

[188]  S. Caldwell,et al.  Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. , 2009, Journal of hepatology.

[189]  Y. N. Park,et al.  Usefulness of FibroScan for Detection of Early Compensated Liver Cirrhosis in Chronic Hepatitis B , 2009, Digestive Diseases and Sciences.

[190]  D. J. Kim,et al.  Non‐invasive model predicting clinically‐significant portal hypertension in patients with advanced fibrosis , 2009, Journal of gastroenterology and hepatology.

[191]  V. Wong,et al.  Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B , 2009, Journal of gastroenterology and hepatology.

[192]  A. Mangia,et al.  SAFE biopsy: A validated method for large‐scale staging of liver fibrosis in chronic hepatitis C , 2009, Hepatology.

[193]  N. Kato,et al.  Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography , 2009, Hepatology.

[194]  Robert Stern,et al.  Role, metabolism, chemical modifications and applications of hyaluronan. , 2009, Current medicinal chemistry.

[195]  Richard D Moore,et al.  Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[196]  Gérard Forzy,et al.  Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C , 2009, Hepatology.

[197]  H. Wedemeyer,et al.  410 FOOD INTAKE INCREASES LIVER STIFFNESS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION , 2009 .

[198]  Sheng-Nan Lu,et al.  FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis , 2009, Journal of Gastroenterology.

[199]  P. Marcellin,et al.  Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest–ActiTest) in patients infected by hepatitis B virus , 2009, Journal of viral hepatitis.

[200]  P. Nahon,et al.  Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case–control study , 2009, European journal of gastroenterology & hepatology.

[201]  P. Couzigou,et al.  Changes of non‐invasive markers and FibroScan values during HCV treatment , 2009, Journal of viral hepatitis.

[202]  V. Wong,et al.  Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[203]  M. Fink,et al.  Quantitative viscoelasticity mapping of human liver using supersonic shear imaging: preliminary in vivo feasibility study. , 2009, Ultrasound in medicine & biology.

[204]  R. Fontana,et al.  Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[205]  Pierre Bedossa,et al.  Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[206]  Y. Ngo,et al.  Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease , 2009, Hepatology.

[207]  A. Chan,et al.  Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B , 2009, Journal of viral hepatitis.

[208]  D. Thabut,et al.  Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers , 2008, PloS one.

[209]  V. Wong,et al.  Evaluation of Alanine Transaminase and Hepatitis B Virus DNA to Predict Liver Cirrhosis in Hepatitis B e Antigen-Negative Chronic Hepatitis B Using Transient Elastography , 2008, The American Journal of Gastroenterology.

[210]  M. Ziol,et al.  Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. , 2008, Journal of hepatology.

[211]  A. West,et al.  Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay , 2008, Hepatology.

[212]  Gunda Millonig,et al.  Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis , 2008, Hepatology.

[213]  M. Brevet,et al.  Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non‐invasive laboratory tests , 2008, Alimentary pharmacology & therapeutics.

[214]  F. Oberti,et al.  Reproducibility of liver stiffness measurement by ultrasonographic elastometry. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[215]  M. Ziol,et al.  Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis , 2008, Alimentary pharmacology & therapeutics.

[216]  V. de Lédinghen,et al.  Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[217]  M. Brunetto,et al.  Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. , 2008, World journal of gastroenterology.

[218]  J. Dufour,et al.  Disproportionally high results of transient elastography in patients with autoimmune hepatitis , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[219]  N. Kato,et al.  Risk Assessment of Hepatocellular Carcinoma in Chronic Hepatitis C Patients by Transient Elastography , 2008, Journal of clinical gastroenterology.

[220]  D. Neau,et al.  Validation and Comparison of Simple Noninvasive Indexes for Predicting Liver Fibrosis in HIV-HCV-Coinfected Patients: ANRS CO3 Aquitaine Cohort , 2008, The American Journal of Gastroenterology.

[221]  F. Marra,et al.  Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis , 2008, Hepatology.

[222]  Y. Ngo,et al.  An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load , 2008, PloS one.

[223]  Ralph Sinkus,et al.  Magnetic resonance elastography for the noninvasive staging of liver fibrosis. , 2008, Gastroenterology.

[224]  V. Wong,et al.  Validation of the NAFLD Fibrosis Score in a Chinese Population With Low Prevalence of Advanced Fibrosis , 2008, The American Journal of Gastroenterology.

[225]  M. Färkkilä,et al.  Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[226]  J. Talwalkar.  Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[227]  F. Oberti,et al.  Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography , 2008, European journal of gastroenterology & hepatology.

[228]  Radu Badea,et al.  Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients. , 2008, Journal of gastrointestinal and liver diseases : JGLD.

[229]  J M Peron,et al.  Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease , 2008, Alimentary pharmacology & therapeutics.

[230]  F. Carrat,et al.  Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02. , 2008, Journal of hepatology.

[231]  Laurent Castera,et al.  Non-invasive evaluation of liver fibrosis using transient elastography. , 2008, Journal of hepatology.

[232]  H. Kirikoshi,et al.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[233]  S. Milani,et al.  Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C , 2008, Gut.

[234]  B. Neuschwander‐Tetri,et al.  Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease , 2008, Gut.

[235]  S. Czernichow,et al.  Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. , 2008, Journal of hepatology.

[236]  Eva Herrmann,et al.  Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. , 2008, Gastroenterology.

[237]  R. Fontana,et al.  Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C , 2008, Hepatology.

[238]  K. Qureshi,et al.  The Utility of the “NAFLD Fibrosis Score” in Morbidly Obese Subjects with NAFLD , 2008, Obesity surgery.

[239]  Richard L Ehman,et al.  Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications , 2007, Hepatology.

[240]  D. Häussinger,et al.  Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage , 2007, Hepatology.

[241]  Massimo Pinzani,et al.  Acute viral hepatitis increases liver stiffness values measured by transient elastography , 2007, Hepatology.

[242]  J. Gisbert,et al.  Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis , 2007, Alimentary pharmacology & therapeutics.

[243]  R. Myers,et al.  FibroTest and FibroScan for the Prediction of Hepatitis C-Related Fibrosis: A Systematic Review of Diagnostic Test Accuracy , 2007, The American Journal of Gastroenterology.

[244]  Patrice Cacoub,et al.  Meta-analyses of FibroTest diagnostic value in chronic liver disease , 2007, BMC gastroenterology.

[245]  J. Macías,et al.  The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[246]  Colin P West,et al.  Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[247]  V. de Lédinghen,et al.  Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. , 2007, Clinical chemistry.

[248]  R. Moreau,et al.  Relationship between the Fibrotest and portal hypertension in patients with liver disease , 2007, Alimentary pharmacology & therapeutics.

[249]  S. Pol,et al.  FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest , 2007, Hepatology.

[250]  Patrice Faure,et al.  Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. , 2007, Journal of hepatology.

[251]  R. Sacco,et al.  Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases , 2007, Journal of viral hepatitis.

[252]  Giacomo Belli,et al.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis , 2007, Hepatology.

[253]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[254]  V. Paradis,et al.  Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. , 2007, Journal of hepatology.

[255]  Yukihiro Kishimoto,et al.  Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C , 2007, Hepatology.

[256]  A. Alberti,et al.  Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. , 2007, World journal of gastroenterology.

[257]  Dario Conte,et al.  Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease , 2007, Gut.

[258]  X. Forns,et al.  Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[259]  Laurent Castera,et al.  Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases , 2006, Hepatology.

[260]  George Kitis,et al.  Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. , 2006, Gastroenterology.

[261]  R. Testa,et al.  Platelet Count/Spleen Diameter Ratio for the Noninvasive Diagnosis of Esophageal Varices: Results of a Multicenter, Prospective, Validation Study , 2006, The American Journal of Gastroenterology.

[262]  R. Bilonick,et al.  Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection , 2006, Hepatology.

[263]  D. Ouzan,et al.  Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies , 2006, Journal of viral hepatitis.

[264]  Y. Ngo,et al.  A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. , 2006, Clinical chemistry.

[265]  N. Ganne-Carrié,et al.  Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. , 2006, Journal of hepatology.

[266]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[267]  M. Ziol,et al.  Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC , 2006, Hepatology.

[268]  M. Rudler,et al.  Non‐invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[269]  Mario Plebani,et al.  Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. , 2006, Journal of hepatology.

[270]  P. Roderick,et al.  Performance of serum marker panels for liver fibrosis in chronic hepatitis C. , 2006, Journal of hepatology.

[271]  Nancy A Obuchowski,et al.  An ROC‐type measure of diagnostic accuracy when the gold standard is continuous‐scale , 2006, Statistics in medicine.

[272]  M. Ziol,et al.  Diagnosis of Hepatic Fibrosis and Cirrhosis by Transient Elastography in HIV/Hepatitis C Virus-Coinfected Patients , 2006, Journal of acquired immune deficiency syndromes.

[273]  F. Oberti,et al.  A novel panel of blood markers to assess the degree of liver fibrosis , 2005, Hepatology.

[274]  Lungen Lu,et al.  Prediction of significant fibrosis in HBeAg‐positive patients with chronic hepatitis B by a noninvasive model , 2005, Hepatology.

[275]  P. Gibson,et al.  Mechanisms by which food intake elevates circulating levels of hyaluronan in humans , 2005, Journal of internal medicine.

[276]  J. Kench,et al.  Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. , 2005, Clinical chemistry.

[277]  F. Zoulim,et al.  Longitudinal Assessment of Histology Surrogate Markers (FibroTest–ActiTest) During Lamivudine Therapy in Patients with Chronic Hepatitis B Infection , 2005, The American Journal of Gastroenterology.

[278]  J. Macías,et al.  Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes , 2005, Gut.

[279]  William M. Lee,et al.  Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT‐C cohort , 2005, Hepatology.

[280]  V. de Lédinghen,et al.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study , 2005, Gut.

[281]  N. Afdhal,et al.  Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. , 2005, Journal of hepatology.

[282]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[283]  V. Wong,et al.  Identification of Chronic Hepatitis B Patients without Significant Liver Fibrosis by a Simple Noninvasive Predictive Model , 2005, The American Journal of Gastroenterology.

[284]  Paul Calès,et al.  Sources of variability in histological scoring of chronic viral hepatitis , 2005, Hepatology.

[285]  V. de Lédinghen,et al.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.

[286]  Christos Christidis,et al.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C , 2005, Hepatology.

[287]  J. Westin,et al.  Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers , 2005, Scandinavian journal of gastroenterology.

[288]  J. Pawlotsky,et al.  Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. , 2004, Journal of hepatology.

[289]  D. Schuppan,et al.  Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.

[290]  D. Thabut,et al.  Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. , 2004, Clinical chemistry.

[291]  R. Malekzadeh,et al.  Reversibility of cirrhosis in autoimmune hepatitis. , 2004, The American journal of medicine.

[292]  J. Kench,et al.  Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index , 2004, Hepatology.

[293]  R. Bruno,et al.  Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. , 2004, Journal of hepatology.

[294]  F. Morel,et al.  Circulating Matrix Metalloproteinases 1, 2, 9 and Their Inhibitors TIMP-1 and TIMP-2 as Serum Markers of Liver Fibrosis in Patients With Chronic Hepatitis C: Comparison With PIIINP and Hyaluronic Acid , 2004, American Journal of Gastroenterology.

[295]  D. Thabut,et al.  Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors , 2004, Clinical chemistry and laboratory medicine.

[296]  V. Paradis,et al.  Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.

[297]  M. Ziol,et al.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.

[298]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[299]  M. Manns,et al.  Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa‐2b and ribavirin , 2003, Hepatology.

[300]  R. Testa,et al.  Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis , 2003, Gut.

[301]  Llorenç Quintó,et al.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model , 2002, Hepatology.

[302]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[303]  M. Manns,et al.  Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. , 2002, Gastroenterology.

[304]  S Chevret,et al.  Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial , 2002, Journal of viral hepatitis.

[305]  Gregg Trahey,et al.  Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. , 2002, Ultrasound in medicine & biology.

[306]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[307]  T. Poynard,et al.  Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.

[308]  M. Sata,et al.  Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy , 2000, Annals of Internal Medicine.

[309]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[310]  J. Delattre,et al.  Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C , 1998, Hepatology.

[311]  M. Kaplan,et al.  Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis , 1997, Annals of Internal Medicine.

[312]  P. Bedossa,et al.  An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.

[313]  J. Ludwig,et al.  The long‐term pathological evolution of chronic hepatitis C , 1996, Hepatology.

[314]  A. Manduca,et al.  Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. , 1995, Science.

[315]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[316]  P. Bedossa,et al.  Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .

[317]  A. Feinstein,et al.  Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. , 1978, The New England journal of medicine.

[318]  Hiroshi Onishi,et al.  Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. , 2015, Magnetic resonance imaging.

[319]  EASL Clinical Practice Guidelines: management of hepatitis C virus infection. , 2014, Journal of hepatology.

[320]  K. Nouso,et al.  Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices. , 2013, Gastroenterology.

[321]  V. de Lédinghen,et al.  Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. , 2012, Journal of hepatology.

[322]  J. Bruix,et al.  Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. , 2012, Journal of hepatology.

[323]  J. Talwalkar,et al.  Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[324]  F. Brunello,et al.  Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. , 2011, Journal of hepatology.

[325]  P. Couzigou,et al.  CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C , 2011 .

[326]  William M. Lee,et al.  Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. , 2010, Gastroenterology.

[327]  V. de Lédinghen,et al.  Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. , 2009, Journal of hepatology.

[328]  Bryan Lau,et al.  Exceeding the limits of liver histology markers. , 2009, Journal of hepatology.

[329]  F. Laine,et al.  Comparison of blood tests for liver fibrosis specific or not to NAFLD. , 2009, Journal of hepatology.

[330]  F. Lammert,et al.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.

[331]  G. Hunault,et al.  Reproducibility of blood tests of liver fibrosis in clinical practice. , 2008, Clinical biochemistry.

[332]  M. Colombo,et al.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.